Drug Shortage Report for SEVOFLURANE
Report ID | 230374 |
Drug Identification Number | 02265974 |
Brand name | SEVOFLURANE |
Common or Proper name | sevoflurane |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | SEVOFLURANE |
Strength(s) | 99.97% |
Dosage form(s) | LIQUID |
Route of administration | INHALATION INHALATION |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 250 ml (CA2L9117, open bottle) |
ATC code | N01AB |
ATC description | ANESTHETICS, GENERAL |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-06-13 |
Actual start date | 2024-06-13 |
Estimated end date | 2024-07-02 |
Actual end date | 2024-07-02 |
Shortage status | Resolved |
Updated date | 2024-07-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-07-03 | English | Compare |
v9 | 2024-07-02 | French | Compare |
v8 | 2024-07-02 | English | Compare |
v7 | 2024-06-25 | French | Compare |
v6 | 2024-06-25 | English | Compare |
v5 | 2024-06-24 | French | Compare |
v4 | 2024-06-24 | English | Compare |
v3 | 2024-06-14 | English | Compare |
v2 | 2024-06-13 | French | Compare |
v1 | 2024-06-13 | English | Compare |
Showing 1 to 10 of 10